These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 8573325

  • 21. Use of interferon beta 1b for multiple sclerosis. Patients will put up with side effects because of their desire to beat the disease.
    Chellingsworth M.
    BMJ; 1996 Nov 16; 313(7067):1263. PubMed ID: 8939140
    [No Abstract] [Full Text] [Related]

  • 22. Neutralizing antibodies and the efficacy of interferon beta-1b in relapsing-remitting multiple sclerosis.
    Petkau J, White R.
    Mult Scler; 1997 Dec 16; 3(6):402. PubMed ID: 9493643
    [No Abstract] [Full Text] [Related]

  • 23. Interferon beta in multiple sclerosis.
    Richards RG.
    BMJ; 1996 Nov 09; 313(7066):1159. PubMed ID: 8916730
    [No Abstract] [Full Text] [Related]

  • 24. Liver injury associated with the beta-interferons for MS.
    Francis GS, Kaplowitz N, Alteri E.
    Neurology; 2004 Sep 28; 63(6):1142-3; author reply 1142-3. PubMed ID: 15457586
    [No Abstract] [Full Text] [Related]

  • 25. Immunotherapy for MS: clinical aspects and trials.
    Ebers GC, Sibley WA, Paty DW.
    Acta Neurol Scand Suppl; 1995 Sep 28; 161():54. PubMed ID: 7653246
    [No Abstract] [Full Text] [Related]

  • 26. [Immunotherapy of multiple sclerosis. Consensus and controversies].
    Hohlfeld R.
    Nervenarzt; 1999 Apr 28; 70(4):297. PubMed ID: 10354989
    [No Abstract] [Full Text] [Related]

  • 27. Multiple sclerosis.
    Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG.
    N Engl J Med; 2000 Sep 28; 343(13):938-52. PubMed ID: 11006371
    [No Abstract] [Full Text] [Related]

  • 28. Multiple sclerosis: new therapeutic concepts or better use of old drugs?
    Clanet M.
    Eur Neurol; 1993 Sep 28; 33(6):401-2. PubMed ID: 8307059
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Anaphylactoid reaction to methyl prednisolone developing after starting treatment with interferon beta-1b.
    Clear D.
    J Neurol Neurosurg Psychiatry; 1999 May 28; 66(5):690. PubMed ID: 10348645
    [No Abstract] [Full Text] [Related]

  • 31. Side effect profile of interferon beta-1b in MS: results of an open label trial.
    Neilley LK, Goodin DS, Goodkin DE, Hauser SL.
    Neurology; 1996 Feb 28; 46(2):552-4. PubMed ID: 8614531
    [Abstract] [Full Text] [Related]

  • 32. Interferon beta treatment for multiple sclerosis: persisting questions.
    Goodkin DE.
    Mult Scler; 1996 Jul 28; 1(6):321-4. PubMed ID: 9345408
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Update on management and genetics of multiple sclerosis.
    Sadovnick AD.
    J Neural Transm Suppl; 1997 Jul 28; 50():167-72. PubMed ID: 9120416
    [Abstract] [Full Text] [Related]

  • 37. Multiple sclerosis therapy. A practical guide.
    van Oosten BW, Truyen L, Barkhof F, Polman CH.
    Drugs; 1995 Feb 28; 49(2):200-12. PubMed ID: 7729328
    [Abstract] [Full Text] [Related]

  • 38. The quality-of-life effects of interferon beta-1b in multiple sclerosis. An extended Q-TWiST analysis.
    Schwartz CE, Coulthard-Morris L, Cole B, Vollmer T.
    Arch Neurol; 1997 Dec 28; 54(12):1475-80. PubMed ID: 9400356
    [Abstract] [Full Text] [Related]

  • 39. Lethal capillary leak syndrome after a single administration of interferon beta-1b.
    Schmidt S, Hertfelder HJ, von Spiegel T, Hering R, Harzheim M, Lassmann H, Deckert-Schlüter M, Schlegel U.
    Neurology; 1999 Jul 13; 53(1):220-2. PubMed ID: 10408566
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.